Merck & Co., Inc.
Market cap $362.4B
$146.63
MRK
$146.63
-0.16% today
Buy with €1M virtual cash · No real money
Merck & Co., Inc. (MRK) is a publicly traded company listed on the XNYS. As of September 19, 2026, Invest's signal rates MRK a Buy, with the stock up 81% over the past year. You can practice trading MRK risk-free with €1,000,000 in virtual cash.
Key stats
As of September 19, 2026
Market Cap
$362.4B
Volume
31.1M
52-wk High
$156.92
52-wk Low
$77.58
Day High
$147.84
Day Low
$145.74
P/E (TTM)
116.37
Revenue (TTM)
$66.6B
EPS (TTM)
$1.26
Performance
1M
-3.7%
6M
+28.4%
1Y
+80.7%
Invest signal · MRK
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
MRK overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +2.0%Revenue
$17BEPS (diluted)
$-0.54 per shareLatest MRK news
Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?
Zacks Investment Research · 19h ago
Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?
Zacks Investment Research · 3d ago
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Zacks Investment Research · 3d ago
Immunotherapy Drugs Market 2026: Precision Medicine, Next-Generation Biologics and Expanding Cancer Indications Fuel Growth Opportunities
GlobeNewswire Inc. · 3d ago
Parexel to Lead Sessions at DPHARM 2026 on AI, Talent and the Future of Clinical Operations
GlobeNewswire Inc. · 4d ago
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus.
Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Employees
75,000
30-Day Win Rate · MRK
9 days
14 days
Last 23 sessions
How to practice trading MRK
- 1
Use the MRK buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top MRK traders on Invest
Full leaderboardFrequently asked questions
Is MRK a good stock to buy right now?
As of September 19, 2026, Invest's signal rates MRK a Buy, based on its price trend, valuation, and fundamentals (P/E around 116.4), with the stock up 81% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading MRK risk-free first.
What is Merck & Co., Inc.'s (MRK) market cap?
Merck & Co., Inc. has a market capitalization of approximately $362.4B, on trailing-twelve-month revenue of about $66.6B.
How has MRK stock performed?
MRK is up 81% over the past year and up 28% over six months. Its 52-week range runs roughly from $77.58 to $156.92. Past performance doesn't predict future results.
How can I practice trading MRK for free?
On Invest you get €1,000,000 in virtual cash and can buy MRK at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare MRK with peers